Maria A. Velez, MD, MS
Languages
Education
Fellowship
Degrees
Residency
Board Certification
Contact Information
Phone
Scientific Interests
Dr. Velez's primary research interests lie in the design and execution of clinical trials focused on patients with lung and head and neck cancers. Additionally, she is dedicated to investigating the barriers that prevent the inclusion of patients from historically underrepresented backgrounds in clinical trials, with a particular focus on those who are non-English speakers.
Highlighted Publications
Zhou N, Velez MA, Bachrach B, Gukasyan J, Fares CM, Cummings AL, Lind- Lebuffe JP, Akingbemi WO, Li DY, Brodrick PM, Yessuf NM, Rettinger S, Grogan T, Rochigneux P, Goldman JW, Garon EB, Lisberg A. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC. Lung cancer (Amsterdam, Netherlands). 2021;161:34-41. Epub 2021/09/11. doi: 10.1016/j.lungcan.2021.08.009. PubMed PMID: 34507111. Dr. Velez is a co-first author on this publication with Dr. Zhou as she played and essential role in the design and analysis of this publication.
Somasundaram A, Cillo AR, Lampenfeld C, Workman CJ, Kunning S, Oliveri L, Velez M, Joyce S, Calderon M, Dadey R, Rajasundaram D, Normolle DP, Watkins SC, Herman JG, Kirkwood JM, Lipson EJ, Ferris RL, Bruno TC, Vignali DAA. Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells. Cancer Immunol Res. 2022;10(7):885-99. Epub 2022/05/20. doi: 10.1158/2326-6066.Cir-20-0736. PubMed PMID: 35587532.
Velez MA, Glenn BA, Garcia-Jimenez M, Cummings AL, Lisberg A, Nañez A, Radwan Y, Lind-Lebuffe JP, Brodrick PM, Li DY, Fernandez-Turizo MJ, Gower A, Lindenbaum M, Hegde M, Brook J, Grogan T, Elashoff D, Teitell MA, Garon EB. Consent document translation expense hinders inclusive clinical trial enrolment. Nature. 2023;620(7975):855-62. Epub 2023/08/03. doi: 10.1038/s41586-023-06382- 0. PubMed PMID: 37532930.
Velez MA, Garon EB. Is There a Place for Temozolomide plus Nivolumab among Neuroendocrine Neoplasms? Clinical cancer research: an official journal of the American Association for Cancer Research. 2023;29(4):691-3. doi: 10.1158/1078- 0432.Ccr-22-3229. PubMed PMID: 36520037.